Free Download: The Missing Link for New Parkinson's Treatments?
Therapies to slow or stop Parkinson's are advancing through development, but they all face a similar challenge: there's no objective measure of their impact on the underlying disease.
What's inside this guide?
- How lack of those measures, called biomarkers, slows testing of new treatments
- How biomarkers can help diagnose Parkinson's
- Where in the body researchers are looking for biomarkers
- How people with and without Parkinson's disease can help identify a biomarker to speed better treatments